Insider Trading & Ownership of David E. I. Pyott

Location: Cambridge, MA
Summary: The estimated net worth of David E. I. Pyott is at least $11,125,517 dollars as of 20 Feb 2026. David E. I. Pyott is the Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $6.71M. David E. I. Pyott is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $3.83M. David E. I. Pyott is the Director of Tarsus Pharmaceuticals, Inc. and owns shares of Tarsus Pharmaceuticals, Inc. (TARS) stock worth about $525.1K. David E. I. Pyott is the Director of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $55.7K.
Signature: /s/ Scott Sieckert, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when David E. I. Pyott files a new Insider Trading report.

Ownership of David E. I. Pyott

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Director	$6,711,522	-$2,224,560	-25%	08 May 2025
BMRN	BIOMARIN PHARMACEUTICAL INC	Director	$3,833,238			21 May 2024
TARS	Tarsus Pharmaceuticals, Inc.	Director	$525,088			18 Feb 2026
PLRX	PLIANT THERAPEUTICS, INC.	Director	$55,669			05 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.